Analysis of c-erbB-2 amplification in salivary gland tumours by differential polymerase chain reaction

Dardick, 1991, Histogenesis and morphogenesis of salivary gland tumors, 108 Schechter, 1984, The neu oncogene: an erbB related gene encoding a 185000-Mr tumour antigen, Nature, 312, 513, 10.1038/312513a0 Bargmann, 1986, Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185, Cell, 45, 649, 10.1016/0092-8674(86)90779-8 Coussens, 1985, Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene, Science, 230, 1132, 10.1126/science.2999974 Semba, 1985, A v-erbB-related proto-oncogene, c-erbB-2, is distinct from the c-erbB-1 epidermal growth factor receptor gene and is amplified in a human salivary gland adenocarcinoma, 82, 6487 Yamamoto, 1986, An erbB-related gene, c-erbB-2, encodes a possible receptor protein similar to epidermoid growth factor receptor, Nature, 319, 230, 10.1038/319230a0 Zhou, 1987, Association of multiple copies of the c-erbB-2 oncogene with the spread of breast cancer, Cancer Res, 47, 6123 Henitz, 1990, Amplification of the c-erbB-2 oncogene and prognosis of breast adenocarcinoma, Arch Pathol Lab Med, 114, 160 Tal, 1988, Sporadic amplification of the HER-2/neu protooncogene in adenocarcinomas of various tissues, Cancer Res, 48, 1517 Zeillinger, 1989, HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer, Oncogene, 4, 109 Tsuda, 1989, Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1int-2 and c-erbB-2/HER-1, Cancer Res, 49, 3104 Borg, 1990, HER-2/neu amplification predicts poor survival in node-positive breast cancer, Cancer Res, 50, 4332 Slamon, 1987, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, 235, 177, 10.1126/science.3798106 Cline, 1987, Proto-oncogene abnormalities in human breast cancer: correlation with anatomic features and clinical course of disease, J. Clin Oncol, 58, 453 Seshadri, 1989, The significance of oncogene amplification in primary breast cancer, Int J Cancer, 43, 270, 10.1002/ijc.2910430218 Guerin, 1989, Structure and expression of c-erbB-2 and ECG receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance, Int J Cancer, 43, 201, 10.1002/ijc.2910430205 Tandon, 1989, HER-2/neu oncogene protein and prognosis in breast cancer, J Clin Oncol, 7, 1120, 10.1200/JCO.1989.7.8.1120 Wright, 1989, Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer, Cancer Res, 49, 2087 McCann, 1991, Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer, Cancer Res, 51, 3296 Lovekin, 1991, C-erbB-2 oncoprotein expression in primary and advanced breast cancer, Br J Cancer, 63, 439, 10.1038/bjc.1991.101 Gullick, 1991, C-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes, Br J Cancer, 63, 434, 10.1038/bjc.1991.100 Winstanley, 1991, The long term prognostic significance of c-erbB-2 in primary breast cancer, Br J Cancer, 63, 447, 10.1038/bjc.1991.103 Gullick, 1989, The c-erbB-2 and its expression in human tumors, 38 Perrin, 1991, C-erbB-2 oncogene as a prognostic marker in breast cancer (editorial), Br J Cancer, 63, 328, 10.1038/bjc.1991.78 Riviere, 1991, Comparative investigation of c-erbB-2/neu expression in head and neck tumors and mammary cancer, Cancer, 67, 2142, 10.1002/1097-0142(19910415)67:8<2142::AID-CNCR2820670823>3.0.CO;2-8 Kernohan, 1991, Expression of c-erbB-2 oncoprotein in salivary gland tumors: an immunohistochemical study, J Pathol, 163, 77, 10.1002/path.1711630113 Kahn, 1992, Expression and amplification of neu oncogene in pleomorphic adenomas of salivary gland, Arch Pathol Lab Med, 116, 80 Birek, 1993, C-fos oncogene under-expression in salivary gland tumors as measured by in situ hybridization, Am J Path, 142, 917 Sugano, 1992, Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness, Laryngoscope, 102, 923, 10.1288/00005537-199208000-00013 Frye, 1989, Detection of amplified oncogenes by differential polymerase chain reaction, Oncogene, 4, 1153 Bernhard, 1987, Isolation of genomic DNA, 180 Kraus, 1987, Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms, EMBO J, 6, 605, 10.1002/j.1460-2075.1987.tb04797.x Jordan RCK, Dardick I, Lui E, Birek C. Demonstration of c-erbB-2 overexpression in salivary gland neoplasms by in situ hybridization. Submitted. Claude, 1991, Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides, Eur J Cancer, 27, 1466, 10.1016/0277-5379(91)90033-A Powis, 1991, Growth factors and oncogene signalling pathways as targets for rational anticancer drug development, Clin Biochem, 24, 385, 10.1016/S0009-9120(05)80014-1 Tominga, 1992, P53 from basic research to clinical applications, Critical Rev Onc, 3, 257